CHOLANGIOCARCINOMA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Cholangiocarcinoma Market, By Cancer Type [Extrahepatic Cholangiocarcinoma (Perihilar, Distal), Intrahepatic Cholangiocarcinoma], By Therapy Type [Targeted Drug Therapy (Pemigatinib, Ivosidenib, Futibatinib, Infigratinib), Chemotherapy (5-Fluorouracil, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin), Immunotherapy (Pembrolizumab, and Others), and Others (Pain Medications and Others)], By Route of Administration (Oral, Subcutaneous, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In: 29 Apr, 2026
Code: CMI4435
Page number: 156
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Cancer Type
  - Market Snippet, By Therapy Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- - Market Dynamics
    - Drivers
    - Restraints
    - Opportunities
  - Recent Product Launches/Approvals
  - Recent Trends
  - Mergers, Acquisitions, and Collaborations
  - Regulatory Scenario
  - Key Developments
  - PEST Analysis
  - PORTER’s Analysis
Global
Cholangiocarcinoma
M
arket, By Cancer Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Extrahepatic Cholangiocarcinoma
  - - Perihilar
    - Distal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Intrahepatic Cholangiocarcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
Global
Cholangiocarcinoma
M
arket, By Therapy Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Targeted Drug Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
    - Pemigatinib
    - Ivosidenib
    - Futibatinib
    - Infigratinib
- Chemotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
    - 5- fluorouracil
    - Gemcitabine
    - Cisplatin
    - Capecitabine
    - Oxaliplatin
- Immunotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
    - Pembrolizumab
    - Others (Late phase pipeline drugs)
- Others (Pain Medications and others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
Global
Cholangiocarcinoma
Market, By
Route of Administration
, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Subcutaneous
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Intravenous
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
Global
Cholangiocarcinoma
Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- E-commerce
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Global
Cholangiocarcinoma
Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, and By Y-o-Y Growth, By Region, 2021 - 2033, (US$ Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - BridgeBio Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sanofi
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Eisai Co., Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Eli Lilly and Company
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Intas Pharmaceuticals Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Fresenius SE & Co. KGaA
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Hikma Pharmaceuticals PLC
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Incyte
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - TRISALUS LIFE SCIENCES, INC.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - GENFIT
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Johnson & Johnson Private Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Bliss Biopharmaceutical
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - LES LABORATOIRES SERVIER
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - F.Hoffmann-La Roche Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Mylan N.V. (Viatris.Inc)
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - AstraZeneca
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Compass Therapeutics, Inc
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Otsuka Holdings Co., Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Senhwa Biosciences, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
- Analysts’ Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 27 market data tables and 31 figures on “Global Cholangiocarcinoma Market” – Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now